Back to the main directory
Press Release
- CV Sciences, Inc. Announces Closing of Committed Equity Financing Transaction by GlobeNewsWire
- Checkmate Pharmaceuticals Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate CMP-001 in Combination with Nivolumab by GlobeNewsWire
- TomaGold annonce le début des forages à Obalski by GlobeNewsWire
- uniQure Presents Late-Breaking Data from the HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B at the 62nd Annual Meeting of the American Society of Hematology by GlobeNewsWire
- Lantronix Provides Advanced IoT Technologies to Flock Safety for Development of Community Safety Solution by GlobeNewsWire
- Sabina Gold & Silver Reports Final Results from Successful 2020 Exploration Season at Back River Project, Nunavut by GlobeNewsWire
- Gilat Receives Multi-Million-Dollar Order for a US Department of Defense Tactical Communications Program by GlobeNewsWire
- Ansys Announces Leadership Appointments by GlobeNewsWire
- Athira Pharma Awarded $15 Million Grant from National Institute on Aging to Support ACT-AD Clinical Trial in Alzheimer’s Disease by GlobeNewsWire
- CloudMD to Present at Benzinga Global Small Cap Conference and LD Micro in December by GlobeNewsWire
- Progenity Announces Closing of the Convertible Senior Notes Offering and Partial Exercise of the Initial Purchaser’s Option to Purchase Additional Notes by GlobeNewsWire
- Plus Therapeutics to Present at 13th Annual LD Micro Main Event Conference by GlobeNewsWire
- DGAP-News: HALIX B.V.: HALIX Signs Agreement With AstraZeneca For Commercial Manufacture Of COVID-19 Vaccine by EQS Group AG
- Banco Comercial Português, S.A. informa sobre requisitos mínimos prudenciais by GlobeNewsWire
- DGAP-News: Hapag-Lloyd raises earnings forecast by EQS Group AG
- DGAP-News: Juva Life stellt erstklassiges wissenschaftliches Führungsteam der Öffentlichkeit vor! by EQS Group AG
- Alico, Inc. Announces Financial Results for the Fourth Quarter and Fiscal Year Ended September 30, 2020, Increases Quarterly Dividend by 100% and Provides Initial Fiscal Year 2021 Financial Guidance by GlobeNewsWire
- BBS-Bioactive Bone Substitutes Oyj: BBS-Bioactive Bone Substitutes Oyj:n 9.11.2020 klo 8:45 yhtiötiedotteessa julkaistu tieto on osoittautunut virheelliseksi by GlobeNewsWire
- Solar Senior Capital Ltd. Announces Monthly Distribution of $0.10 Per Share for December 2020 by GlobeNewsWire
- electroCore Announces Positive Top-Line Results from PREMIUM II Migraine Prevention Study by GlobeNewsWire
- Kronos Bio Appoints Pasit Phiasivongsa, Ph.D., as Senior Vice President, Pharmaceutical Development by GlobeNewsWire
- H2O Innovation présente son plan stratégique de trois ans by GlobeNewsWire
- Bragg Gaming CEO Adam Arviv Named to Hot 50 of 2021 Rising Stars and Emerging Leaders by GlobeNewsWire
- Gear4 Introduces Apple-Exclusive Cases Made for MagSafe for the Apple iPhone 12 mini, iPhone 12, iPhone 12 Pro, and iPhone 12 Pro Max by GlobeNewsWire
- Altimmune Commences Dosing in Phase 1 Clinical Trial of ALT-801, a Long-Acting GLP-1/Glucagon Receptor Dual Agonist for the Treatment of NASH by GlobeNewsWire